The eleventh-hour legislative deal reached in Congress on New Year’s Day to avert the so-called fiscal cliff addresses looming tax increases but merely postpones another major element – implementation of the federal budget sequestration scheduled to go into effect Jan. 1. The American Taxpayer Relief Act, H.R. 8 – which passed the House and Senate Jan. 1 and was signed by President Obama Jan. 3 – delays until March 1 across-the-board government spending cuts that will impact funding for FDA’s regulatory programs ([A#02121008007]). Negotiations on possible cuts in entitlement programs will continue over the next two months. More than $300 million will be trimmed from FDA’s budget if proposed funding cuts are enacted, representing a reduction of about 8%.
In the closing weeks of 2012, the European Chemicals Agency added 54 Substances of Very High Concern to its candidate...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?